HopeStage
Back to all studies
CompletedNCT01553084

Varenicline or Nicotine Replacement to Help People Stop Smoking

About this titleRead the official source — NCT01553084
Medication studyAges 18–99United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 99 years.

Listed locations
Madison and 1 more locationSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMay 2012
Recruitment status
Completed
Enrollment listed in the registry
1,086
Sponsor
University of Wisconsin, Madison
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 18 Years to 99 Years
Official registry ID
NCT01553084
Official title
Show the full official title

A Comparative Effectiveness & Long Term Health Study in Wisconsin Smokers

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Madison · Milwaukee

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Wisconsin, Madison, a university.

Did this study involve medication?

Yes. The study involved medication, including Varenicline, Nicotine lozenge and Nicotine Patch.

Who was this study for?

Listed age limits: 18 years to 99 years.

Want to explore more studies?

Explore studies